PD Aplan

749 total citations
8 papers, 603 citations indexed

About

PD Aplan is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, PD Aplan has authored 8 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in PD Aplan's work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). PD Aplan is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). PD Aplan collaborates with scholars based in United States and Ukraine. PD Aplan's co-authors include Martin Stanulla, David L. Caudell, C. Glenn Begley, Michael P. Davey, Thomas A. Waldmann, Kenneth Nakahara, Kathryn M. Tchorz, Joanne Kurtzberg, Michael S. Hershfield and B F Haynes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Leukemia.

In The Last Decade

PD Aplan

8 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
PD Aplan United States	7	386	238	236	104	84	8	603
David Mbangkollo United States	6	376 1.0×	184 0.8×	369 1.6×	78 0.8×	54 0.6×	8	631
Yebin Ahn United States	3	389 1.0×	238 1.0×	251 1.1×	96 0.9×	102 1.2×	4	601
IR Kirsch United States	9	304 0.8×	162 0.7×	212 0.9×	146 1.4×	123 1.5×	17	603
LC Chan China	5	180 0.5×	243 1.0×	367 1.6×	167 1.6×	70 0.8×	5	588
Koyu Hoshino United States	12	543 1.4×	125 0.5×	452 1.9×	57 0.5×	88 1.0×	21	739
Nathalie Lecointe France	9	279 0.7×	120 0.5×	135 0.6×	168 1.6×	36 0.4×	11	487
Agnieszka A. Wendorff United States	6	446 1.2×	139 0.6×	179 0.8×	100 1.0×	99 1.2×	8	642
Ryoichi Ono Japan	13	584 1.5×	96 0.4×	428 1.8×	49 0.5×	78 0.9×	22	815
Enrica Privitera Italy	13	232 0.6×	265 1.1×	313 1.3×	47 0.5×	56 0.7×	26	534
HA Drabkin United States	11	436 1.1×	77 0.3×	310 1.3×	47 0.5×	53 0.6×	16	582

Countries citing papers authored by PD Aplan

Since Specialization

Citations

This map shows the geographic impact of PD Aplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PD Aplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PD Aplan more than expected).

Fields of papers citing papers by PD Aplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PD Aplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PD Aplan. The network helps show where PD Aplan may publish in the future.

Co-authorship network of co-authors of PD Aplan

This figure shows the co-authorship network connecting the top 25 collaborators of PD Aplan. A scholar is included among the top collaborators of PD Aplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PD Aplan. PD Aplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Caudell, David L. & PD Aplan. (2007). The role of CALM–AF10 gene fusion in acute leukemia. Leukemia. 22(4). 678–685. 54 indexed citations

2.

Aplan, PD, et al.. (2007). Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Leukemia. 21(6). 1276–1284. 24 indexed citations

3.

Aplan, PD, et al.. (2001). Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice. Leukemia. 15(1). 141–147. 14 indexed citations

4.

Jaju, R J, Carrie Fidler, Fiona Watkins, et al.. (2000). A novel gene is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood AML.. Blood. 96(11). 2 indexed citations

5.

Aplan, PD, et al.. (1996). Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors [see comments]. Blood. 87(7). 2649–2658. 144 indexed citations

6.

Aplan, PD, et al.. (1992). Involvement of the putative hematopoietic transcription factor SCL in T- cell acute lymphoblastic leukemia. Blood. 79(5). 1327–1333. 114 indexed citations

7.

Aplan, PD, et al.. (1992). Involvement of the putative hematopoietic transcription factor SCL in T- cell acute lymphoblastic leukemia. Blood. 79(5). 1327–1333. 12 indexed citations

8.

Begley, C. Glenn, PD Aplan, Michael P. Davey, et al.. (1989). Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript.. Proceedings of the National Academy of Sciences. 86(6). 2031–2035. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact